Literature DB >> 28613916

Human CD8+ T Cells Damage Noninfected Epithelial Cells during Influenza Virus Infection In Vitro.

Carolien E van de Sandt1, Montserrat Bárcena2, Abraham J Koster2, Jennifer Kasper3, Charles J Kirkpatrick3, Dana P Scott4, Rory D de Vries1, Susanne Herold5, Guus F Rimmelzwaan1, Thijs Kuiken1, Kirsty R Short1,6,7.   

Abstract

During severe influenza A virus (IAV) infections, a large amount of damage to the pulmonary epithelium is the result of the antiviral immune response. Specifically, whilst CD8+ T cells are important for killing IAV-infected cells, during a severe IAV infection, they can damage uninfected epithelial cells. At present, the mechanisms by which this occurs are unclear. Here, we used a novel in vitro coculture model of human NCl-H441 cells and CD8+ T cells to provide a new insight into how CD8+ T cells may affect uninfected epithelial cells during severe IAV infections. Using this model, we show that human IAV-specific CD8+ T cells produce soluble factors that reduce the barrier integrity of noninfected epithelial cells (referred to as "bystander damage"). We show that this bystander damage is the result of a combination of TNF-α and IFN-γ. This bystander damage occurred in the absence of widespread epithelial cell death and was instead associated with decreased expression of epithelial cell ion channels and pumps. Together, these data suggest that ameliorating the function of epithelial cell ion channels and pumps may help reduce immunopathology during severe IAV infections.

Entities:  

Keywords:  CD8+ T cells; bystander damage; epithelial cells; influenza virus

Mesh:

Substances:

Year:  2017        PMID: 28613916     DOI: 10.1165/rcmb.2016-0377OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  17 in total

1.  Heterotypic Influenza Infections Mitigate Susceptibility to Secondary Bacterial Infection.

Authors:  Ellyse M Cipolla; Molin Yue; Kara L Nickolich; Brydie R Huckestein; Danielle Antos; Wei Chen; John F Alcorn
Journal:  J Immunol       Date:  2022-08-01       Impact factor: 5.426

2.  Interferon-γ promotes monocyte-mediated lung injury during influenza infection.

Authors:  Taylor Schmit; Kai Guo; Jitendra Kumar Tripathi; Zhihan Wang; Brett McGregor; Mitch Klomp; Ganesh Ambigapathy; Ramkumar Mathur; Junguk Hur; Michael Pichichero; Jay Kolls; M Nadeem Khan
Journal:  Cell Rep       Date:  2022-03-01       Impact factor: 9.995

3.  Testosterone treatment of aged male mice improves some but not all aspects of age-associated increases in influenza severity.

Authors:  Landon G Vom Steeg; Sarah E Attreed; Barry Zirkin; Sabra L Klein
Journal:  Cell Immunol       Date:  2019-09-14       Impact factor: 4.868

4.  COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets.

Authors:  Toni M Delorey; Carly G K Ziegler; Graham Heimberg; Rachelly Normand; Yiming Yang; Åsa Segerstolpe; Domenic Abbondanza; Stephen J Fleming; Ayshwarya Subramanian; Daniel T Montoro; Karthik A Jagadeesh; Kushal K Dey; Pritha Sen; Michal Slyper; Yered H Pita-Juárez; Devan Phillips; Jana Biermann; Zohar Bloom-Ackermann; Nikolaos Barkas; Andrea Ganna; James Gomez; Johannes C Melms; Igor Katsyv; Erica Normandin; Pourya Naderi; Yury V Popov; Siddharth S Raju; Sebastian Niezen; Linus T-Y Tsai; Katherine J Siddle; Malika Sud; Victoria M Tran; Shamsudheen K Vellarikkal; Yiping Wang; Liat Amir-Zilberstein; Deepak S Atri; Joseph Beechem; Olga R Brook; Jonathan Chen; Prajan Divakar; Phylicia Dorceus; Jesse M Engreitz; Adam Essene; Donna M Fitzgerald; Robin Fropf; Steven Gazal; Joshua Gould; John Grzyb; Tyler Harvey; Jonathan Hecht; Tyler Hether; Judit Jané-Valbuena; Michael Leney-Greene; Hui Ma; Cristin McCabe; Daniel E McLoughlin; Eric M Miller; Christoph Muus; Mari Niemi; Robert Padera; Liuliu Pan; Deepti Pant; Carmel Pe'er; Jenna Pfiffner-Borges; Christopher J Pinto; Jacob Plaisted; Jason Reeves; Marty Ross; Melissa Rudy; Erroll H Rueckert; Michelle Siciliano; Alexander Sturm; Ellen Todres; Avinash Waghray; Sarah Warren; Shuting Zhang; Daniel R Zollinger; Lisa Cosimi; Rajat M Gupta; Nir Hacohen; Hanina Hibshoosh; Winston Hide; Alkes L Price; Jayaraj Rajagopal; Purushothama Rao Tata; Stefan Riedel; Gyongyi Szabo; Timothy L Tickle; Patrick T Ellinor; Deborah Hung; Pardis C Sabeti; Richard Novak; Robert Rogers; Donald E Ingber; Z Gordon Jiang; Dejan Juric; Mehrtash Babadi; Samouil L Farhi; Benjamin Izar; James R Stone; Ioannis S Vlachos; Isaac H Solomon; Orr Ashenberg; Caroline B M Porter; Bo Li; Alex K Shalek; Alexandra-Chloé Villani; Orit Rozenblatt-Rosen; Aviv Regev
Journal:  Nature       Date:  2021-04-29       Impact factor: 69.504

5.  Androgen receptor signaling in the lungs mitigates inflammation and improves the outcome of influenza in mice.

Authors:  Landon G Vom Steeg; Santosh Dhakal; Yishak A Woldetsadik; Han-Sol Park; Kathleen R Mulka; Emma C Reilly; David J Topham; Sabra L Klein
Journal:  PLoS Pathog       Date:  2020-07-09       Impact factor: 6.823

Review 6.  From virus to inflammation, how influenza promotes lung damage.

Authors:  Mitchell Klomp; Sumit Ghosh; Sohail Mohammed; M Nadeem Khan
Journal:  J Leukoc Biol       Date:  2020-09-08       Impact factor: 6.011

7.  Immune Response of A Novel ATR-AP205-001 Conjugate Anti-hypertensive Vaccine.

Authors:  Xiajun Hu; Yihuan Deng; Xiao Chen; Yanzhao Zhou; Hongrong Zhang; Hailang Wu; Shijun Yang; Fen Chen; Zihua Zhou; Min Wang; Zhihua Qiu; Yuhua Liao
Journal:  Sci Rep       Date:  2017-10-03       Impact factor: 4.379

8.  High glucose levels increase influenza-associated damage to the pulmonary epithelial-endothelial barrier.

Authors:  Katina D Hulme; Limin Yan; Rebecca J Marshall; Conor J Bloxham; Kyle R Upton; Sumaira Z Hasnain; Helle Bielefeldt-Ohmann; Zhixuan Loh; Katharina Ronacher; Keng Yih Chew; Linda A Gallo; Kirsty R Short
Journal:  Elife       Date:  2020-07-22       Impact factor: 8.140

Review 9.  Advancements in Host-Based Interventions for Influenza Treatment.

Authors:  Tsz-Fung Yip; Aisha Sami Mohammed Selim; Ida Lian; Suki Man-Yan Lee
Journal:  Front Immunol       Date:  2018-07-10       Impact factor: 7.561

Review 10.  Harnessing the Power of T Cells: The Promising Hope for a Universal Influenza Vaccine.

Authors:  E Bridie Clemens; Carolien van de Sandt; Sook San Wong; Linda M Wakim; Sophie A Valkenburg
Journal:  Vaccines (Basel)       Date:  2018-03-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.